Shweta Maniar: After attending the J.P. Morgan Healthcare Conference in San Francisco, I want to share some of my key takeaways
Shweta Maniar, Global Director, Healthcare and Life Sciences at shared on their LinkedIn:
”After attending the J.P. Morgan Healthcare Conference (jpm2024 ) in San Francisco, I want to share some of my key takeaways:
– Despite economic headwinds, companies continued to drive innovation in gene therapy, oncology, and other promising areas.
– M and A activity may have slowed, but strategic partnerships and collaborations are becoming more important for sharing costs and risks.
– Drug pricing and healthcare policy remain top of mind. Companies are working to find the balance between innovation and affordability.
– The rise of digital therapeutics, multi-modal ‘omics’ and the integration of AI into drug discovery show that digital health is here to stay.
– The emphasis on patient-centricity highlights the importance of including patient perspectives in drug development and care. Patients continue to be the stewards of their health data.
What are other takeaways?
It was energizing to see the future of healthcare innovation unfold at jpm2024. Excited to see how these trends will shape the industry in the year ahead! And a big thank you to everyone who braved the rain and wind of SF to make this conference a success. See you next year!
I leave you with a photo of how beautiful the area looked one of the evenings.”
Source: Shweta Maniar/LinkedIn
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023